These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34927775)

  • 1. Epithelioid cell granuloma formation in CARD14-associated papulosquamous eruptions.
    Takeichi T; Ikeda K; Muro Y; Ogi T; Morizane S; Akiyama M
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):e369-e371. PubMed ID: 34927775
    [No Abstract]   [Full Text] [Related]  

  • 2. Histopathologic findings characteristic of CARD14-associated papulosquamous eruption.
    Ring NG; Craiglow BG; Panse G; Antaya RJ; Ashack K; Ashack R; Faith EF; Paller AS; McNiff JM; Choate KA; Ko CJ
    J Cutan Pathol; 2020 May; 47(5):425-430. PubMed ID: 31849081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.
    Craiglow BG; Boyden LM; Hu R; Virtanen M; Su J; Rodriguez G; McCarthy C; Luna P; Larralde M; Humphrey S; Holland KE; Hogeling M; Hidalgo-Matlock B; Ferrari B; Fernandez-Faith E; Drolet B; Cordoro KM; Bowcock AM; Antaya RJ; Ashack K; Ashack RJ; Lifton RP; Milstone LM; Paller AS; Choate KA
    J Am Acad Dermatol; 2018 Sep; 79(3):487-494. PubMed ID: 29477734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation in a CARD14-associated papulosquamous eruption.
    Li N; Tao J; Zhang J; Liu Z; Yu P
    Pediatr Dermatol; 2023; 40(4):706-709. PubMed ID: 36724903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARD14-associated papulosquamous eruption (CAPE) in a toddler responding to treatment with acitretin.
    Wong GHZ; Chia SY; Wei H; Rafi'ee K; Koh MJA; Tan EC
    Pediatr Dermatol; 2021 Jul; 38(4):970-972. PubMed ID: 34075616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CARD14-associated papulosquamous eruption (CAPE) in pediatric patients: Three additional cases and review of the literature.
    Frare CP; Blumstein AJ; Paller AS; Pieretti L; Choate KA; Bowcock AM; Larralde M
    Pediatr Dermatol; 2021 Sep; 38(5):1237-1242. PubMed ID: 34448248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical response of CARD14-associated papulosquamous eruption to an anti-interleukin-17A antibody.
    Klein B; Treudler R; Dumann K; Boldt A; Schumann I; Simon JC; Kunz M
    Br J Dermatol; 2022 Sep; 187(3):419-422. PubMed ID: 35262907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial pityriasis rubra pilaris is caused by mutations in CARD14.
    Fuchs-Telem D; Sarig O; van Steensel MA; Isakov O; Israeli S; Nousbeck J; Richard K; Winnepenninckx V; Vernooij M; Shomron N; Uitto J; Fleckman P; Richard G; Sprecher E
    Am J Hum Genet; 2012 Jul; 91(1):163-70. PubMed ID: 22703878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with ustekinumab in CARD14-associated papulosquamous eruption in a Brazilian child.
    Kiszewski AE; De Almeida HL
    Dermatol Ther; 2022 Dec; 35(12):e15939. PubMed ID: 36239488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A child with CARD14-associated papulosquamous eruption (CAPE) successfully treated with ustekinumab.
    Nogueira M; Reis J; Abreu M; Coelho A; Reis CF; Machado S
    Pediatr Dermatol; 2023; 40(6):1104-1106. PubMed ID: 37219506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14.
    Eytan O; Sarig O; Sprecher E; van Steensel MA
    Br J Dermatol; 2014 Aug; 171(2):420-2. PubMed ID: 24641799
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial pityriasis rubra pilaris in a Chinese family caused by a novel mutation in CARD14 gene.
    Wu T; Banerjee S; Deng J; Wu J; Huang H; Zheng H; Pan H; Wang Y; Peng Z; Sun X
    Indian J Dermatol Venereol Leprol; 2020; 86(1):81-84. PubMed ID: 31755479
    [No Abstract]   [Full Text] [Related]  

  • 13. CARD14-mutations in pityriasis rubra pilaris and therapeutic response to ustekinumab - a hypothesis.
    Volc-Platzer B
    J Dtsch Dermatol Ges; 2020 Nov; 18(11):1312-1315. PubMed ID: 32881385
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of CARD14-negative juvenile Pityriasis rubra pilaris with Ustekinumab.
    Reitmajer M; Forchhammer S; Silber T
    J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e512-e514. PubMed ID: 38084925
    [No Abstract]   [Full Text] [Related]  

  • 15. Target-sequence Capture and High Throughput Sequencing Identify a De novo CARD14 Mutation in an Infant with Erythrodermic Pityriasis Rubra Pilaris.
    Has C; Schwieger-Briel A; Schlipf N; Hausser I; Chmel N; Rösler B; Technau K; Jakob T; Zimmer A; Fischer J
    Acta Derm Venereol; 2016 Nov; 96(7):989-990. PubMed ID: 27140437
    [No Abstract]   [Full Text] [Related]  

  • 16. CARD14 Glu138 mutation in familial pityriasis rubra pilaris does not warrant differentiation from familial psoriasis.
    Inoue N; Dainichi T; Fujisawa A; Nakano H; Sawamura D; Kabashima K
    J Dermatol; 2016 Feb; 43(2):187-9. PubMed ID: 26130407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of CARD14 in non-familial pityriasis rubra pilaris: a case series.
    Hong JB; Chen PL; Chen YT; Tsai TF
    Acta Derm Venereol; 2014 Sep; 94(5):587-8. PubMed ID: 24577624
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased epidermal expression and absence of mutations in CARD14 in a series of patients with sporadic pityriasis rubra pilaris.
    Eytan O; Qiaoli L; Nousbeck J; van Steensel MA; Burger B; Hohl D; Taïeb A; Prey S; Bachmann D; Avitan-Hersh E; Jin Chung H; Shemer A; Trau H; Bergman R; Fuchs-Telem D; Warshauer E; Israeli S; Itin PH; Sarig O; Uitto J; Sprecher E
    Br J Dermatol; 2014 May; 170(5):1196-8. PubMed ID: 24359224
    [No Abstract]   [Full Text] [Related]  

  • 19. The beneficial effect of a PDE4 inhibitor in a patient with juvenile-onset intractable pityriasis rubra pilaris without CARD14 mutation.
    Inoue E; Arase N; Hanaoka Y; Tanemura A; Fujimoto M
    Dermatol Ther; 2021 Jan; 34(1):e14714. PubMed ID: 33368948
    [No Abstract]   [Full Text] [Related]  

  • 20. Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations.
    Takeichi T; Sugiura K; Nomura T; Sakamoto T; Ogawa Y; Oiso N; Futei Y; Fujisaki A; Koizumi A; Aoyama Y; Nakajima K; Hatano Y; Hayashi K; Ishida-Yamamoto A; Fujiwara S; Sano S; Iwatsuki K; Kawada A; Suga Y; Shimizu H; McGrath JA; Akiyama M
    JAMA Dermatol; 2017 Jan; 153(1):66-70. PubMed ID: 27760266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.